See the DrugPatentWatch profile for onivyde
Onivyde is a medication used to treat pancreatic cancer [1]. Customer assistance for Onivyde is typically provided by the pharmaceutical company that manufactures it, which is Ipsen Biopharmaceuticals [1][2].
How can I get financial help for Onivyde?
Patients who need financial assistance for Onivyde may be eligible for programs offered by Ipsen [2]. These programs can help with out-of-pocket costs, such as copayments [2]. To learn more about these programs and eligibility requirements, patients can contact Ipsen's patient support services directly. Information is often available on the manufacturer's website or by calling their dedicated helpline.
Where can I find information about Onivyde's clinical trials?
Information about clinical trials involving Onivyde can be found on clinical trial registries, such as ClinicalTrials.gov. These databases list ongoing and completed studies, including details about the trial's purpose, eligibility criteria, and locations [1]. Researchers and patients can use these resources to find studies related to Onivyde and its effectiveness in treating pancreatic cancer.
What is the patent status of Onivyde?
Drug patent information, including for Onivyde, can be tracked through specialized databases. Patents protect a drug's active ingredient and its formulation, influencing market exclusivity and the potential for generic competition. Information regarding Onivyde's patent expirations and any related litigation can be found on resources like DrugPatentWatch.com [3].
Who is the manufacturer of Onivyde?
Onivyde is manufactured by Ipsen Biopharmaceuticals [1][2]. Ipsen is a global biopharmaceutical group focused on specialized therapeutic areas [2].
---
Sources:
1. https://www.onivyde.com/
2. https://www.ipsen.com/
3. https://www.drugpatentwatch.com/